Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1432)	10/3/2005 10:47:24 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

Re: AVII The stock needs to close above its July 13-14-16 triple top a the 2.50 level. Well, it should be able to do that today.<g> It is now trading at 2.98 and hasn't closed it opening upgap.<g> The volume is still below Friday's but at 1,043,610 is already above the daily average. bigcharts.marketwatch.com They announced today that the U.S. Senate Committee on Appropriations approved $22M for AVII's research programs as part of the defense spending bill for 2006. "AVII believes its NEUGENE antisense 'rapid response therapeutics' have a significant role to play in the future of bioterrorism defense." Bernard